Health in Cote d'Ivoire

1,376 indicators covering health for Cote d'Ivoire.

IndicatorLatest Year10-yr change Rank
3.1.2 Proportion of births attended by skilled health personnel 74 2016 up 30.3% 141st
Inflation-adjusted prices for most sold brand of cigarettes: Prices 3.41 2022 down 7.6% 139th
Taxes as a % of price: total tax 39.5% 2022 up 55.8% 133rd
Taxes as a % of price: value added tax 15.2% 2022 up 40.9% 50th
Taxes as a % of price: ad valorem excise 24.2% 2022 up 102.3% 52nd
Taxes as a % of price: specific excise 0.0% 2022 135th
Taxes as a % of price: import duties 0.0% 2022 38th
Taxes as a % of price: other taxes 0.0% 2022 down 100.0% 57th
Vitamin A supplementation coverage rate 85.0% 2023 down 14.1% 17th
Inflation-adjusted prices for most sold brand of cigarettes: Price in 800 2022 down 4.9% 31st
Weight-for-height <-3 SD 2.39 2021 up 197.3% 10th
Prevalence of severe wasting, weight for height 2.4% 2021 up 200.0% 8th
Physical activity policies for activie societies 20 2023 down 35.5% 2nd
Physical activity policies focused on active systems 10 2023 down 67.7% 101st
Midwifery personnel 10,710 2024 up 102.1% 28th
Number of deaths from malaria who 10,817 2024 up 13.1% 17th
Death rate from malaria 33.87 2024 down 13.1% 25th
Incidence of malaria 267.95 2024 up 10.2% 13th
Share of one year olds who received the final dose of pneumococcal vac 75 2024 up 3,650.0% 114th
Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 75 2024 up 3,650.0% 114th
Death rate from poisonings 1 2021 up 11.1% 54th
3.8.1 Coverage of essential health services 43 2021 up 30.3% 171st
Rotavirus number unvaccinated 213,633 2023 down 64.6% 25th
Share of deaths registered 25.5 2019 140th
Prevalence of stunting, height for age 23.4% 2021 down 14.0% 39th
Affordability - percentage of GDP per capita required to purchase 5.33 2022 down 34.4% 67th
Malaria cases reported 8.52 million 2024 up 129.4% 9th
Deaths and missing persons due to natural disasters 0.23 2023 up 130.0% 77th
Mean systolic blood pressure 128.8 2009 up 0.6% 47th
Mean fasting blood glucose (mmol/l) 5.3 2009 up 1.9% 95th
Hiv expenditure 0 2020 down 100.0% 101st
Number of new leprosy cases with G2D among children 5 2024 9th
Neonates protected at birth against neonatal tetanus (PAB) 83.0% 2022 up 1.2% 74th
Prevalence of overweight, weight for height 3.4% 2021 up 112.5% 63rd
Most sold brand of cigarettes - price in currency reported 700 2020 unchanged 35th
Most sold brand of cigarettes - taxes as a % of price - total tax 0.3% 2020 up 40.0% 145th
Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.2% 2020 up 33.3% 67th
Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 34th
Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 unchanged 19th
Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 up 36.4% 48th
Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 129th
Most sold brand of cigarettes - price in US$ at official exchange 1.26 2020 down 9.4% 140th
Number healthy diet unaffordable 15.50 million 2024 up 3.3% 28th
Import of environmentally sound technologies 691.08 million 2019 up 97.6% 90th
Most sold brand of cigarettes - price in PPP$ 2.87 2020 down 4.0% 148th
Export of environmentally sound technologies 153.65 million 2019 up 15.8% 82nd
Pcv3 number unvaccinated 195,057 2023 down 75.6% 24th
Reported number of human rabies deaths 21 2024 up 23.5% 16th
Proportion of births delivered in a health facility (Facility births) 80.9% 2021 up 40.9% 102nd
Number of non-autochthonous leprosy cases 0 2024 47th
Estimated number of children (aged 0-17 years) who have lost one or 310,000 2024 down 40.4% 12th
Prevalence of wasting, weight for height, female 7.1% 2021 up 65.1% 18th
Prevalence of wasting, weight for height, male 9.0% 2021 up 42.9% 18th
Number reported cases of cholera 12 2021 down 99.0% 50th
Population with basic handwashing facilities at home 11.1% 2024 up 29.5% 104th
Prevalence of severe wasting, weight for height, female 1.9% 2021 up 137.5% 13th
Prevalence of severe wasting, weight for height, male 2.9% 2021 up 262.5% 6th
Prevalence of overweight, weight for height, female 3.1% 2021 up 158.3% 57th
Prevalence of overweight, weight for height, male 3.8% 2021 up 100.0% 53rd
HPV immunization coverage estimates among primary target cohort (9-14) 90.0% 2025 up 1,400.0% 19th